APO Research
Talk to an analyst

APO RESEARCH · REPORT

Knee Osteoarthritis Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Knee Osteoarthritis Treatment Market Analysis and Forecast 2026-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchKnee Osteoarthritis Treatment Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Knee Osteoarthritis Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Knee Osteoarthritis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Knee Osteoarthritis Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Knee Osteoarthritis Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Knee Osteoarthritis Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Knee Osteoarthritis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Knee Osteoarthritis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Knee Osteoarthritis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Knee Osteoarthritis Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Knee Osteoarthritis Treatment include Anika Therapeutics, AVM Biotechnology, Bioventus, Flexion Therapeutics, Horizon Therapeutics, OrthoTrophix, Bayer, GlaxoSmithKline and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Knee Osteoarthritis Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Knee Osteoarthritis Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Knee Osteoarthritis Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Knee Osteoarthritis Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Knee Osteoarthritis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Knee Osteoarthritis Treatment revenue, projected growth trends, production technology, application and end-user industry.

Knee Osteoarthritis Treatment Segment by Company

Anika Therapeutics

AVM Biotechnology

Bioventus

Flexion Therapeutics

Horizon Therapeutics

OrthoTrophix

Bayer

GlaxoSmithKline

Pfizer

Eli Lilly

Johnson and Johnson

Sanofi

Abbott

Knee Osteoarthritis Treatment Segment by Type

Non-surgical Treatment

Surgical Treatment

Knee Osteoarthritis Treatment Segment by Application

Ambulatory Surgical Centers

Hospitals

Specialty Clinics

Others

Knee Osteoarthritis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Knee Osteoarthritis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Knee Osteoarthritis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Knee Osteoarthritis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Knee Osteoarthritis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Knee Osteoarthritis Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Knee Osteoarthritis Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Non-surgical Treatment Major Player Table 3. Surgical Treatment Major Player Table 4. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Ambulatory Surgical Centers Major Player Table 6. Hospitals Major Player Table 7. Specialty Clinics Major Player Table 8. Others Major Player Table 9. Knee Osteoarthritis Treatment Industry Trends Table 10. Knee Osteoarthritis Treatment Industry Drivers Table 11. Knee Osteoarthritis Treatment Industry Opportunities and Challenges Table 12. Knee Osteoarthritis Treatment Industry Restraints Table 13. Global Knee Osteoarthritis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Knee Osteoarthritis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Knee Osteoarthritis Treatment Market Share by Region (2021-2026) Table 16. Global Knee Osteoarthritis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Knee Osteoarthritis Treatment Market Share by Region (2027-2032) Table 18. Global Knee Osteoarthritis Treatment Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Knee Osteoarthritis Treatment Revenue Market Share by Players (2021-2026) Table 20. Global Knee Osteoarthritis Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Knee Osteoarthritis Treatment Key Players Headquarters & Area Served Table 22. Global Knee Osteoarthritis Treatment Players, Product Type & Application Table 23. Global Knee Osteoarthritis Treatment Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Knee Osteoarthritis Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Knee Osteoarthritis Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Knee Osteoarthritis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Knee Osteoarthritis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Knee Osteoarthritis Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Knee Osteoarthritis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Knee Osteoarthritis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2027-2032) Table 36. Anika Therapeutics Company Information Table 37. Anika Therapeutics Business Overview Table 38. Anika Therapeutics Knee Osteoarthritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Anika Therapeutics Knee Osteoarthritis Treatment Product Portfolio Table 40. Anika Therapeutics Recent Development Table 41. AVM Biotechnology Company Information Table 42. AVM Biotechnology Business Overview Table 43. AVM Biotechnology Knee Osteoarthritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. AVM Biotechnology Knee Osteoarthritis Treatment Product Portfolio Table 45. AVM Biotechnology Recent Development Table 46. Bioventus Company Information Table 47. Bioventus Business Overview Table 48. Bioventus Knee Osteoarthritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Bioventus Knee Osteoarthritis Treatment Product Portfolio Table 50. Bioventus Recent Development Table 51. Flexion Therapeutics Company Information Table 52. Flexion Therapeutics Business Overview Table 53. Flexion Therapeutics Knee Osteoarthritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Flexion Therapeutics Knee Osteoarthritis Treatment Product Portfolio Table 55. Flexion Therapeutics Recent Development Table 56. Horizon Therapeutics Company Information Table 57. Horizon Therapeutics Business Overview Table 58. Horizon Therapeutics Knee Osteoarthritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Horizon Therapeutics Knee Osteoarthritis Treatment Product Portfolio Table 60. Horizon Therapeutics Recent Development Table 61. OrthoTrophix Company Information Table 62. OrthoTrophix Business Overview Table 63. OrthoTrophix Knee Osteoarthritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. OrthoTrophix Knee Osteoarthritis Treatment Product Portfolio Table 65. OrthoTrophix Recent Development Table 66. Bayer Company Information Table 67. Bayer Business Overview Table 68. Bayer Knee Osteoarthritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Bayer Knee Osteoarthritis Treatment Product Portfolio Table 70. Bayer Recent Development Table 71. GlaxoSmithKline Company Information Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline Knee Osteoarthritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. GlaxoSmithKline Knee Osteoarthritis Treatment Product Portfolio Table 75. GlaxoSmithKline Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Knee Osteoarthritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Pfizer Knee Osteoarthritis Treatment Product Portfolio Table 80. Pfizer Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly Knee Osteoarthritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Eli Lilly Knee Osteoarthritis Treatment Product Portfolio Table 85. Eli Lilly Recent Development Table 86. Johnson and Johnson Company Information Table 87. Johnson and Johnson Business Overview Table 88. Johnson and Johnson Knee Osteoarthritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Johnson and Johnson Knee Osteoarthritis Treatment Product Portfolio Table 90. Johnson and Johnson Recent Development Table 91. Sanofi Company Information Table 92. Sanofi Business Overview Table 93. Sanofi Knee Osteoarthritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sanofi Knee Osteoarthritis Treatment Product Portfolio Table 95. Sanofi Recent Development Table 96. Abbott Company Information Table 97. Abbott Business Overview Table 98. Abbott Knee Osteoarthritis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Abbott Knee Osteoarthritis Treatment Product Portfolio Table 100. Abbott Recent Development Table 101. North America Knee Osteoarthritis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Knee Osteoarthritis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Knee Osteoarthritis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Knee Osteoarthritis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Knee Osteoarthritis Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Knee Osteoarthritis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Knee Osteoarthritis Treatment Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Knee Osteoarthritis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Knee Osteoarthritis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Knee Osteoarthritis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Knee Osteoarthritis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Knee Osteoarthritis Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Knee Osteoarthritis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Knee Osteoarthritis Treatment Revenue by Country (US$ Million) & (2027-2032) Table 115. China Knee Osteoarthritis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 116. China Knee Osteoarthritis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 117. China Knee Osteoarthritis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 118. China Knee Osteoarthritis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Knee Osteoarthritis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Knee Osteoarthritis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Knee Osteoarthritis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Knee Osteoarthritis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Knee Osteoarthritis Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Knee Osteoarthritis Treatment Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Knee Osteoarthritis Treatment Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Knee Osteoarthritis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Knee Osteoarthritis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Knee Osteoarthritis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Knee Osteoarthritis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Knee Osteoarthritis Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Knee Osteoarthritis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Knee Osteoarthritis Treatment Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Knee Osteoarthritis Treatment Image Figure 2. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Knee Osteoarthritis Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Non-surgical Treatment Image Figure 5. Surgical Treatment Image Figure 6. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Knee Osteoarthritis Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Ambulatory Surgical Centers Image Figure 9. Hospitals Image Figure 10. Specialty Clinics Image Figure 11. Others Image Figure 12. Global Knee Osteoarthritis Treatment Market Size (US$ Million) & (2021-2032) Figure 13. Global Knee Osteoarthritis Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Knee Osteoarthritis Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Knee Osteoarthritis Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Knee Osteoarthritis Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Knee Osteoarthritis Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Knee Osteoarthritis Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Knee Osteoarthritis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Knee Osteoarthritis Treatment Revenue Share by Type (2021-2032) Figure 25. North America Knee Osteoarthritis Treatment Revenue Share by Application (2021-2032) Figure 26. North America Knee Osteoarthritis Treatment Revenue Share by Country (2021-2032) Figure 27. United States Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Knee Osteoarthritis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Knee Osteoarthritis Treatment Revenue Share by Type (2021-2032) Figure 32. Europe Knee Osteoarthritis Treatment Revenue Share by Application (2021-2032) Figure 33. Europe Knee Osteoarthritis Treatment Revenue Share by Country (2021-2032) Figure 34. Germany Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Knee Osteoarthritis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Knee Osteoarthritis Treatment Revenue Share by Type (2021-2032) Figure 44. China Knee Osteoarthritis Treatment Revenue Share by Application (2021-2032) Figure 45. Asia Knee Osteoarthritis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Knee Osteoarthritis Treatment Revenue Share by Type (2021-2032) Figure 47. Asia Knee Osteoarthritis Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Knee Osteoarthritis Treatment Revenue Share by Region (2021-2032) Figure 49. Japan Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Knee Osteoarthritis Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Knee Osteoarthritis Treatment Revenue Share by Type (2021-2032) Figure 57. SAMEA Knee Osteoarthritis Treatment Revenue Share by Application (2021-2032) Figure 58. SAMEA Knee Osteoarthritis Treatment Revenue Share by Country (2021-2032) Figure 59. Brazil Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Knee Osteoarthritis Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Non-surgical Treatment
  • Surgical Treatment
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics
  • Others
Companies covered
  • Anika Therapeutics
  • AVM Biotechnology
  • Bioventus
  • Flexion Therapeutics
  • Horizon Therapeutics
  • OrthoTrophix
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Johnson and Johnson
  • Sanofi
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Knee Osteoarthritis Treatment Market by Type
  3. 1.2.1 Global Knee Osteoarthritis Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Non-surgical Treatment
  5. 1.2.3 Surgical Treatment
  6. 1.3 Knee Osteoarthritis Treatment Market by Application
  7. 1.3.1 Global Knee Osteoarthritis Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Ambulatory Surgical Centers
  9. 1.3.3 Hospitals
  10. 1.3.4 Specialty Clinics
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Knee Osteoarthritis Treatment Market Dynamics
  1. 2.1 Knee Osteoarthritis Treatment Industry Trends
  2. 2.2 Knee Osteoarthritis Treatment Industry Drivers
  3. 2.3 Knee Osteoarthritis Treatment Industry Opportunities and Challenges
  4. 2.4 Knee Osteoarthritis Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Knee Osteoarthritis Treatment Market Perspective (2021-2032)
  2. 3.2 Global Knee Osteoarthritis Treatment Growth Trends by Region
  3. 3.2.1 Global Knee Osteoarthritis Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Knee Osteoarthritis Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Knee Osteoarthritis Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Knee Osteoarthritis Treatment Revenue by Players
  2. 4.1.1 Global Knee Osteoarthritis Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Knee Osteoarthritis Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Knee Osteoarthritis Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Knee Osteoarthritis Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Knee Osteoarthritis Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Knee Osteoarthritis Treatment Players, Product Type & Application
  8. 4.5 Global Knee Osteoarthritis Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Knee Osteoarthritis Treatment Market CR5 and HHI
  11. 4.6.3 2025 Knee Osteoarthritis Treatment Tier 1, Tier 2, and Tier 3
5 Knee Osteoarthritis Treatment Market Size by Type
  1. 5.1 Global Knee Osteoarthritis Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Knee Osteoarthritis Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2021-2032)
6 Knee Osteoarthritis Treatment Market Size by Application
  1. 6.1 Global Knee Osteoarthritis Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Knee Osteoarthritis Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Anika Therapeutics
  2. 7.1.1 Anika Therapeutics Company Information
  3. 7.1.2 Anika Therapeutics Business Overview
  4. 7.1.3 Anika Therapeutics Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Anika Therapeutics Knee Osteoarthritis Treatment Product Portfolio
  6. 7.1.5 Anika Therapeutics Recent Developments
  7. 7.2 AVM Biotechnology
  8. 7.2.1 AVM Biotechnology Company Information
  9. 7.2.2 AVM Biotechnology Business Overview
  10. 7.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AVM Biotechnology Knee Osteoarthritis Treatment Product Portfolio
  12. 7.2.5 AVM Biotechnology Recent Developments
  13. 7.3 Bioventus
  14. 7.3.1 Bioventus Company Information
  15. 7.3.2 Bioventus Business Overview
  16. 7.3.3 Bioventus Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bioventus Knee Osteoarthritis Treatment Product Portfolio
  18. 7.3.5 Bioventus Recent Developments
  19. 7.4 Flexion Therapeutics
  20. 7.4.1 Flexion Therapeutics Company Information
  21. 7.4.2 Flexion Therapeutics Business Overview
  22. 7.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Flexion Therapeutics Knee Osteoarthritis Treatment Product Portfolio
  24. 7.4.5 Flexion Therapeutics Recent Developments
  25. 7.5 Horizon Therapeutics
  26. 7.5.1 Horizon Therapeutics Company Information
  27. 7.5.2 Horizon Therapeutics Business Overview
  28. 7.5.3 Horizon Therapeutics Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Horizon Therapeutics Knee Osteoarthritis Treatment Product Portfolio
  30. 7.5.5 Horizon Therapeutics Recent Developments
  31. 7.6 OrthoTrophix
  32. 7.6.1 OrthoTrophix Company Information
  33. 7.6.2 OrthoTrophix Business Overview
  34. 7.6.3 OrthoTrophix Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 OrthoTrophix Knee Osteoarthritis Treatment Product Portfolio
  36. 7.6.5 OrthoTrophix Recent Developments
  37. 7.7 Bayer
  38. 7.7.1 Bayer Company Information
  39. 7.7.2 Bayer Business Overview
  40. 7.7.3 Bayer Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bayer Knee Osteoarthritis Treatment Product Portfolio
  42. 7.7.5 Bayer Recent Developments
  43. 7.8 GlaxoSmithKline
  44. 7.8.1 GlaxoSmithKline Company Information
  45. 7.8.2 GlaxoSmithKline Business Overview
  46. 7.8.3 GlaxoSmithKline Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GlaxoSmithKline Knee Osteoarthritis Treatment Product Portfolio
  48. 7.8.5 GlaxoSmithKline Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer Knee Osteoarthritis Treatment Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 Eli Lilly
  56. 7.10.1 Eli Lilly Company Information
  57. 7.10.2 Eli Lilly Business Overview
  58. 7.10.3 Eli Lilly Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Eli Lilly Knee Osteoarthritis Treatment Product Portfolio
  60. 7.10.5 Eli Lilly Recent Developments
  61. 7.11 Johnson and Johnson
  62. 7.11.1 Johnson and Johnson Company Information
  63. 7.11.2 Johnson and Johnson Business Overview
  64. 7.11.3 Johnson and Johnson Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Johnson and Johnson Knee Osteoarthritis Treatment Product Portfolio
  66. 7.11.5 Johnson and Johnson Recent Developments
  67. 7.12 Sanofi
  68. 7.12.1 Sanofi Company Information
  69. 7.12.2 Sanofi Business Overview
  70. 7.12.3 Sanofi Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Sanofi Knee Osteoarthritis Treatment Product Portfolio
  72. 7.12.5 Sanofi Recent Developments
  73. 7.13 Abbott
  74. 7.13.1 Abbott Company Information
  75. 7.13.2 Abbott Business Overview
  76. 7.13.3 Abbott Knee Osteoarthritis Treatment Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Abbott Knee Osteoarthritis Treatment Product Portfolio
  78. 7.13.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Knee Osteoarthritis Treatment Revenue (2021-2032)
  2. 8.2 North America Knee Osteoarthritis Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Knee Osteoarthritis Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Knee Osteoarthritis Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Knee Osteoarthritis Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Knee Osteoarthritis Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Knee Osteoarthritis Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Knee Osteoarthritis Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Knee Osteoarthritis Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Knee Osteoarthritis Treatment Revenue by Country
  11. 8.6.1 North America Knee Osteoarthritis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Knee Osteoarthritis Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Knee Osteoarthritis Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Knee Osteoarthritis Treatment Revenue (2021-2032)
  2. 9.2 Europe Knee Osteoarthritis Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Knee Osteoarthritis Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Knee Osteoarthritis Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Knee Osteoarthritis Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Knee Osteoarthritis Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Knee Osteoarthritis Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Knee Osteoarthritis Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Knee Osteoarthritis Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Knee Osteoarthritis Treatment Revenue by Country
  11. 9.6.1 Europe Knee Osteoarthritis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Knee Osteoarthritis Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Knee Osteoarthritis Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Knee Osteoarthritis Treatment Revenue (2021-2032)
  2. 10.2 China Knee Osteoarthritis Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Knee Osteoarthritis Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Knee Osteoarthritis Treatment Revenue by Type (2027-2032)
  5. 10.3 China Knee Osteoarthritis Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Knee Osteoarthritis Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Knee Osteoarthritis Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Knee Osteoarthritis Treatment Revenue by Application (2027-2032)
  9. 10.5 China Knee Osteoarthritis Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Knee Osteoarthritis Treatment Revenue (2021-2032)
  2. 11.2 Asia Knee Osteoarthritis Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Knee Osteoarthritis Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Knee Osteoarthritis Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Knee Osteoarthritis Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Knee Osteoarthritis Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Knee Osteoarthritis Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Knee Osteoarthritis Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Knee Osteoarthritis Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Knee Osteoarthritis Treatment Revenue by Country
  11. 11.6.1 Asia Knee Osteoarthritis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Knee Osteoarthritis Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Knee Osteoarthritis Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Knee Osteoarthritis Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Knee Osteoarthritis Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Knee Osteoarthritis Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Knee Osteoarthritis Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Knee Osteoarthritis Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Knee Osteoarthritis Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Knee Osteoarthritis Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Knee Osteoarthritis Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Knee Osteoarthritis Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Knee Osteoarthritis Treatment Revenue by Country
  11. 12.6.1 SAMEA Knee Osteoarthritis Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Knee Osteoarthritis Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Knee Osteoarthritis Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst